JUPITER NEUROSCIENCES, INC. financials

JUNS CIK 0001679628

Source: EDGAR filings · Built 2026-06-19T02:37:55Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024
Working Capital -2.57M 2.64M -5.74M
Net Debt 1.53M -3.70M 1.84M
Gross Margin 80.59%
Operating Margin -40873.19%
Net Margin -39662.77%
Return on Equity (ROE) 471.92% -58.48% 82.46%
Return on Assets (ROA) -155.37% -39.33% -3219.34%
Current Ratio 0.65× 2.31× 0.01×
Debt-to-Equity -2.90× 0.02× -0.32×
Cash Conversion Ratio 0.63× 1.60× 0.10×
Accruals Ratio -0.58× 0.24× -28.96×
SBC % of Revenue 11096.15%

Income Statement

Concept FY 2025FY 2024FY 2024
Revenues 21.80K
Cost of Goods and Services Sold 4.23K
Gross Profit 17.57K
Research and Development Expense 2.09M 492.66K 954.79K
Selling, General and Administrative Expense 6.84M
Operating Expenses 8.93M 3.09M 3.87M
Operating Income (Loss) -8.91M -3.09M -3.87M
Net Income (Loss) Attributable to Parent -8.64M -2.44M -4.78M
Earnings Per Share, Basic $-0.25 $-0.08 $-0.18
Weighted Average Number of Shares Outstanding, Basic 34.63M 28.78M 26.41M
Earnings Per Share, Diluted $-0.25 $-0.08 $-0.18
Weighted Average Number of Shares Outstanding, Diluted 34.63M 28.78M 26.41M

Balance Sheet

Concept FY 2025FY 2024FY 2024
Assets, Current 4.82M 4.65M 28.74K
Assets 5.56M 6.20M 148.59K
Liabilities, Current 7.40M 2.01M 5.77M
Liabilities 7.40M 2.03M 5.95M
Stockholders' Equity Attributable to Parent -1.83M 4.17M -5.80M
Common Stock, Shares, Outstanding 34.45M 33.10M 26.53M

Cash Flow Statement

Concept FY 2025FY 2024FY 2024
Net Cash Provided by (Used in) Operating Activities -5.41M -3.91M -480.95K
Net Cash Provided by (Used in) Financing Activities 5.43M 7.65M 445.00K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (JUNS CIK 0001679628), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ARDT

Ardent Health, Inc.

GTLL

GLOBAL TECHNOLOGIES, LTD

RAAQW

REAL ASSET ACQUISITION CORP.